scispace - formally typeset
A

Ana Gleisner

Researcher at Anschutz Medical Campus

Publications -  103
Citations -  3715

Ana Gleisner is an academic researcher from Anschutz Medical Campus. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 25, co-authored 83 publications receiving 3109 citations. Previous affiliations of Ana Gleisner include University of Pittsburgh & Johns Hopkins University.

Papers
More filters
Journal ArticleDOI

Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer

TL;DR: After pancreaticoduodenectomy for adenocarcinoma of the pancreas, LNR was one of the most powerful predictors of survival and should be considered when stratifying patients in future clinical trials.
Journal ArticleDOI

Simultaneous Resections of Colorectal Cancer and Synchronous Liver Metastases: A Multi-institutional Analysis

TL;DR: Simultaneous colorectal and minor hepatic resections are safe and should be performed for most patients with SCRLM and caution should be exercised before performing simultaneous coloreCTal and major liver metastases resections.
Journal ArticleDOI

Preoperative Chemotherapy for Colorectal Liver Metastases: Impact on Hepatic Histology and Postoperative Outcome

TL;DR: The type of hepatic injury after preoperative chemotherapy was regimen-specific and the perioperative complication rate was similar between the no-chemotherapy group and the chemotherapy group (35.3%) (p = 0.79).
Journal ArticleDOI

Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implications for Re-resection

TL;DR: Although common duct resection does not yield a greater lymph node count, it should be performed at the time of re-resection for patients with positive cystic duct margins because over one-third will have residual disease in the common bile duct.
Journal ArticleDOI

Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy: implications for transplant eligibility.

TL;DR: Selection of candidates for transplantation based on NCB tumors grade may be misleading, as NCB tumor grade often did not correlate with grade or presence of microscopic vascular invasion on final pathology.